$1.420
-0.048 (-3.40%)收盤時
- High
- 1.500
- Open
- 1.480
- VWAP
- 1.43
- Vol
- 602.72K
- Mkt Cap
- —
- Low
- 1.355
- Amount
- 858.87K
- EV/EBITDA, TTM
- -0.75
Quantum Cyber N.V., formerly known as Mainz Biomed N.V., is a Germany‑based technology company engaged in the development of solutions in the fields of quantum computing and cybersecurity. The Company focuses on safeguarding digital infrastructure against emerging quantum‑related risks through technologies such as post‑quantum cryptography and defence‑related systems. Its activities include the development of applications supporting secure data protection and communication, as well as the establishment of a platform for quantum‑focused security technologies.
AI analysis of Quantum Cyber NV (QUCY)
buyMainz Biomed NV (QUCY) appears to be a good buy right now due to its recent strong performance, with a year-to-date change of +68.23% and a positive market reaction to significant orders worth $2.09 million. However, the main risk is the potential dilution from the CEO's $6 million investment, which could impact existing shareholders if he sells his shares.
估值指標
事件時間軸
資訊
5.008-25NewsfilterQuantum Cyber Appoints New Head of U.S. Sales to Drive Commercialization
8.507-29GlobenewswireQuantum Cyber Releases Drone Supply Chain Framework
- 8.507-29Newsfilter
Quantum Cyber Releases Drone Supply Chain Framework
8.507-27GlobenewswireQuantum Cyber Completes First Mini-Interceptor Drone Production
- 8.507-27Newsfilter
Quantum Cyber Completes Production of First Mini-Interceptor Drone
QUCY FAQ — answered by Alphio AI
Quantum Cyber N.V., formerly known as Mainz Biomed N.V., is a Germany‑based technology company engaged in the development of solutions in the fields of quantum computing and cybersecurity. The Company focuses on safeguarding digital infrastructure against emerging quantum‑related risks through technologies such as post‑quantum cryptography and defence‑related systems. Its activities include the development of applications supporting secure data protection and communication, as well as the establishment of a platform for quantum‑focused security technologies. It operates in the Technology sector.
Mainz Biomed NV (QUCY) appears to be a good buy right now due to its recent strong performance, with a year-to-date change of +68.23% and a positive market reaction to significant orders worth $2.09 million. However, the main risk is the potential dilution from the CEO's $6 million investment, which could impact existing shareholders if he sells his shares.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。